An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology-Reference-Cited by-同舟云学术

An EU perspective on the use of in vitro methods in regulatory pharmaceutical toxicology

Published:2002-02 Issue:1-3 Volume:127 Page:161-168
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Snodin David J.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference20 articles.

1. Application of complementary DNA microarray technology to carcinogen identification, toxicology and drug safety evaluation;Afshari;Cancer Res.,1999

2. Induction of chromosome aberrations in vitro by phenolphthalein: mechanistic studies;Armstrong;Mutat. Res.,2000

3. In vitro Methods in Toxicology;Atterwill,1987

4. The integrated use of alternative methods in toxicological risk evaluation;Blaauboer;ATLA—Altern. Lab. Anim. Sci.,1999

5. CPMP, 1997a. Points to Consider in the Assessment of the Potential for QT interval Prolongation by Non-cardiovascular Medicinal Products. CPMP/986/96.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of computational techniques for the prediction of drug side effects;Drug Development Research;2020-04-20

2. What can nanosafety learn from drug development? The feasibility of “safety by design”;Nanotoxicology;2017-03-16

3. Toxicoproteomics in human health and disease: an update;Expert Review of Proteomics;2016-11-11

4. Data Mining in Drug Discovery and Design;Artificial Neural Network for Drug Design, Delivery and Disposition;2016

5. Scaffold and cell line based approaches for QSAR studies on anticancer agents;RSC Advances;2015